Detalhe da pesquisa
1.
Ethical approval for controlled human infectious model clinical trial protocols - A workshop report.
Biologicals
; 85: 101748, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350349
2.
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report.
Biologicals
; 85: 101750, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360428
3.
Enabling the evaluation of COVID-19 vaccines with correlates of protection.
Biologicals
; 85: 101723, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976940
4.
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.
Biologicals
; 85: 101745, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341355
5.
Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.
Biologicals
; 85: 101747, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350825
6.
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.
Biologicals
; 85: 101746, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309984
7.
IABS/DCVMN webinar on next generation sequencing.
Biologicals
; 81: 101662, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543633
8.
Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals.
Biologicals
; 83: 101696, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478506
9.
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic.
Biologicals
; 69: 76-82, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234420
10.
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
Biologicals
; 71: 55-60, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966960
11.
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.
Biologicals
; 74: 16-23, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620540
12.
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
Biologicals
; 67: 69-74, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829985
13.
Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report.
Biologicals
; 66: 41-52, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505512
14.
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019.
Biologicals
; 66: 53-61, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389512
15.
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.
Biologicals
; 66: 35-40, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600951
16.
Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals.
Biologicals
; 67: 94-111, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32660862
17.
Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017.
Biologicals
; 61: 85-94, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29573967
18.
Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
Biologicals
; 60: 1-7, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130313
19.
Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.
Biologicals
; 55: 1-16, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30093175
20.
Predictive markers of safety and immunogenicity of adjuvanted vaccines.
Biologicals
; 41(6): 458-68, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071553